- Report
- February 2024
- 204 Pages
Global
From €7579EUR$7,950USD£6,460GBP
- Report
- May 2024
- 128 Pages
Global
From €6196EUR$6,499USD£5,281GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4719EUR$4,950USD£4,022GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4719EUR$4,950USD£4,022GBP
- Report
- March 2024
- 180 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- March 2024
- 198 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- February 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- March 2024
- 199 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- March 2024
- 181 Pages
Global
From €3217EUR$3,374USD£2,742GBP
€3574EUR$3,749USD£3,046GBP
- Report
- January 2024
- 150 Pages
Global
From €4624EUR$4,850USD£3,941GBP
- Report
- June 2024
- 194 Pages
Global
From €4719EUR$4,950USD£4,022GBP
- Report
- January 2024
- 175 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- November 2023
- 250 Pages
Global
From €4767EUR$5,000USD£4,063GBP
- Report
- May 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,372GBP
- Report
- March 2024
- 200 Pages
Global
From €3956EUR$4,150USD£3,372GBP
- Report
- January 2024
- 147 Pages
Global
€4762EUR$4,995USD£4,059GBP
- Report
- October 2023
- 180 Pages
Global
From €4571EUR$4,795USD£3,896GBP
- Report
- January 2024
- 255 Pages
Global
From €4571EUR$4,795USD£3,896GBP
- Report
- September 2023
- 121 Pages
North America
From €2573EUR$2,699USD£2,193GBP
- Report
- January 2024
- 100 Pages
Africa
From €3618EUR$3,795USD£3,084GBP
Uveitis is a medical condition that affects the uvea, the middle layer of the eye. It is characterized by inflammation of the uvea, which can lead to vision loss and other complications. In the context of optical, uveitis is a major cause of vision loss and can be treated with a variety of treatments, including topical and systemic medications, laser treatments, and surgery.
Uveitis is a growing market in the optical industry, as it is a common cause of vision loss and can be treated with a variety of treatments. Companies in the uveitis market include Bausch + Lomb, Novartis, Allergan, and Santen Pharmaceuticals. These companies offer a range of treatments for uveitis, including topical and systemic medications, laser treatments, and surgery. Show Less Read more